Sickle cell disease (SCD) is an inherited red blood cell disorder caused by a structural abnormality of haemoglobin called sickle haemoglobin (HbS) which encodes haemoglobin subunit β. HbS is inherited in an autosomal recessive way and can occur due to homozygosity for HbS (HbSS). HbS is functional and soluble when oxygenated, but upon deoxygenation, it polymerizes, leading to the generation of deformed red blood cells known as sickled cells and dense erythrocytes. The Sickle Cell Disease market report provides a comprehensive analysis of the historic, current, and forecasted Sickle Cell Disease market trends by analyzing the impact of current therapies on the market, unmet needs, drivers and barriers and demand for better technology. For more details visit: https://www.delveinsight.com/report-store/sickle-cell-disease-market